Cytek Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cytek Biosciences, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, detailing director elections, executive compensation, and auditor ratification.
NASDAQ
Cytek Biosciences, Inc. has filed a definitive proxy statement related to its upcoming shareholder meeting.
NASDAQ
Cytek Biosciences will hold its 2025 Annual Meeting of Stockholders virtually on June 18, 2025, to elect directors, approve executive compensation, and ratify the selection of its independent accounting firm.
NASDAQ
Cytek Biosciences, Inc. has filed a definitive proxy statement related to its upcoming shareholder meeting.
NASDAQ
Cytek Biosciences will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to vote on director elections, executive compensation, and the ratification of its independent accounting firm.